REFERENCES
1. Oh JH, Jun DW. The latest global burden of liver cancer: a past and present threat. Clin Mol Hepatol. 2023;29:355-7.
2. Huang DQ, Singal AG, Kono Y, Tan DJH, El-Serag HB, Loomba R. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab. 2022;34:969-77.e2.
3. Diaz LA, Winder GS, Leggio L, Bajaj JS, Bataller R, Arab JP. New insights into the molecular basis of alcohol abstinence and relapse in alcohol-associated liver disease. Hepatology. 2025;82:254-71.
4. Ding C, Ng Fat L, Britton A, et al. Binge-pattern alcohol consumption and genetic risk as determinants of alcohol-related liver disease. Nat Commun. 2023;14:8041.
5. Jophlin LL, Singal AK, Bataller R, et al. ACG clinical guideline: alcohol-associated liver disease. Am J Gastroenterol. 2024;119:30-54.
6. Yu S, Wang S, Li J, et al. Detection of metabolic signatures implicated in the progression from hepatitis to cirrhosis to hepatocellular carcinoma. ILIVER. 2024;4:100142.
7. Ouyang W, Wang MD, Guan MC, et al. Diagnostic performance comparisons of two commonly used multi-biomarker-based scores for detection of hepatocellular carcinoma in non-alcoholic fatty liver disease. ILIVER. 2024;3:100098.
8. Fu Y, Maccioni L, Wang XW, Greten TF, Gao B. Alcohol-associated liver cancer. Hepatology. 2024;80:1462-79.
9. Singal AK, Mathurin P. Diagnosis and treatment of alcohol-associated liver disease: a review. JAMA. 2021;326:165-76.
10. Choi S, Kim BK, Yon DK, et al. Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990-2019: a DALY-based analysis of the Global Burden of Disease 2019 study. Clin Mol Hepatol. 2023;29:433-52.
11. Deng Y, Tan J, Zu J, et al. Trends and health inequalities of hepatitis virus-associated liver cancer mortality during 1990-2050. Ann Hepatol. 2026;31:102144.
12. Global status report on alcohol and health and treatment of substance use disorders. Geneva: World Health Organization. 2024. Available from: https://www.who.int/publications/i/item/9789240096745. [Last accessed on 17 Jun 2026].
14. Niu X, Zhu L, Xu Y, et al. Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis. BMC Public Health. 2023;23:859.
15. Li Q, Ding C, Cao M, et al. Global epidemiology of liver cancer 2022: an emphasis on geographic disparities. Chin Med J. 2024;137:2334-42.
16. Hernández-Évole H, Jiménez-Esquivel N, Pose E, Bataller R. Alcohol-associated liver disease: epidemiology and management. Ann Hepatol. 2024;29:101162.
18. Su H, Wei Y, Liao X, et al. Interpretation of the updates of the chinese guidelines for the diagnosis and treatment of primary liver cancer (CNLC-2024 Edition). Hepatoma Res. 2024;10:30.
19. Pinheiro PS, Jones PD, Medina H, et al. Incidence of etiology-specific hepatocellular carcinoma: diverging trends and significant heterogeneity by race and ethnicity. Clin Gastroenterol Hepatol. 2024;22:562-71.e8.
20. Kim D, Alshuwaykh O, Dennis BB, Cholankeril G, Ahmed A. Trends in etiology-based mortality from chronic liver disease before and during COVID-19 pandemic in the United States. Clin Gastroenterol Hepatol. 2022;20:2307-16.e3.
21. Deutsch-Link S, Jiang Y, Peery AF, Barritt AS, Bataller R, Moon AM. Alcohol-associated liver disease mortality increased from 2017 to 2020 and accelerated during the COVID-19 pandemic. Clin Gastroenterol Hepatol. 2022;20:2142-4.e2.
22. Kasiske BL, Lentine KL, Ahn Y, et al. OPTN/SRTR 2020 annual data report: living donor collective. Am J Transplant. 2022;22:553-86.
23. Younossi ZM, Stepanova M, Al Shabeeb R, et al. The changing epidemiology of adult liver transplantation in the United States in 2013-2022: the dominance of metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease. Hepatol Commun. 2024;8:e0352.
24. Arab JP, Addolorato G, Mathurin P, Thursz MR. Alcohol-associated liver disease: integrated management with alcohol use disorder. Clin Gastroenterol Hepatol. 2023;21:2124-34.
25. Rezaee-Zavareh MS, Liang J, Yang JD. Ethnic disparities in the epidemiology, treatment, and outcome of patients with hepatocellular carcinoma in the United States. Hepatoma Res. 2023;9:18.
26. Shen X, Wang L, Zhang X, Liu J, Wang L, Zhu L. Analysis of forty years of geographic disparity in liver cancer mortality and the influence of risk factors. Ann Am Assoc Geogr. 2022;112:563-80.
27. World Health Organization. Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (SDG Indicator 3.5.2). In: Repository GHOD, editor. 2025. Available from: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/total-(recorded-unrecorded)-alcohol-per-capita-(15-)-consumption. [Last accessed on 17 Jun 2026].
28. Kim SY, Kim HJ. Trends in alcohol consumption for korean adults from 1998 to 2018: korea national health and nutritional examination survey. Nutrients. 2021;13:609.
29. Hong JW, Noh JH, Kim DJ. The prevalence of and factors associated with high-risk alcohol consumption in Korean adults: the 2009-2011 Korea National Health and Nutrition Examination Survey. PLoS One. 2017;12:e0175299.
